RightFit
RecruitingPhase 4

CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
12 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a program to help community health centers prescribe SMART (Single Maintenance and Reliever Therapy), a recommended asthma treatment. It gives care teams training, feedback, and teaching tools. The study will check whether the program increases SMART prescribing and reduces asthma flare-ups in patients ages 12 and older with moderate-to-severe asthma.

Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers. The investigators will roll out these resources in stages across clinics. The study will measure how well the program helps clinicians prescribe SMART therapy and whether it reduces asthma exacerbations in patients.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Clinics must be part of Affinia Healthcare or Family Care Health Centers and have cared for at least 100 patients ages 12 and older with asthma in 2024.
  • Clinicians must be doctors, nurse practitioners, or physician assistants working at a participating clinic while the program is put in place.
  • Clinicians must have cared for at least 10 patients ages 12 and older with asthma in the 12 months before the program starts.
  • Staff must work at a participating clinic while the program is put in place and directly support care for patients ages 12 and older with asthma.
  • Patients must be age 12 or older and receive care at a participating clinic while the program is put in place.
  • Patients must meet the study's rules for moderate-to-severe asthma, based on diagnosis records, medicine use, and/or past asthma flare-ups.

Who can't join

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    The study population can be viewed from the cluster (clinic), clinician, staff, or patient level. At the cluster (clinic) level: To be eligible to participate in this study, a cluster (clinic) must meet all the following criteria: (1) Clinics within participating health systems (Affinia Healthcare and Family Care Health Centers) will be considered eligible if they provided care to ≥100 patients aged ≥12 years with asthma (ICD-10-CM: J45.xx) during the calendar year preceding implementation (2024). At the clinician level: Clinicians will be considered eligible if they: 1. are physicians, nurse practitioners, or physician assistants; 2. are actively employed at a participating clinic during the implementation period; and 3. provided care to ≥10 patients aged ≥12 years with asthma (ICD-10-CM: J45.xx) during the 12 months preceding implementation. At the staff level: Staff will be considered eligible if they: 1. are actively employed at a participating clinic during the implementation period; and 2. directly support clinical care delivery for patients aged ≥12 years with asthma. At the patient level: Patients will be considered eligible if they: 1. are aged ≥12 years; 2. received care at a participating clinic during the implementation period; and (3) meet the study-defined definition of moderate-to-severe asthma based on diagnosis codes, medication use, and/or exacerbation history as defined in the study protocol.

    Study sites (7)

    MO